Capricor Therapeutics (CAPR) Q3 2024 Earnings

7AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.36
-0.24
-0.13
-0.02

Details

Expected EPS
-0.356
Actual EPS
-0.35
Surprise EPS
0.01
Surprise Percent
+1.69%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.35 per share for Q3 2024.

0 Comments

Share your thoughts